A SBIR Phase I contract was awarded to Simpore in May, 2020 for $235,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase II contract was awarded to Simpore in August, 2021 for $667,570.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase I contract was awarded to Simpore in September, 2019 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase II contract was awarded to Simpore in March, 2022 for $893,657.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase I contract was awarded to Simpore in March, 2018 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A STTR Phase I contract was awarded to Simpore in July, 2016 for $198,938.0 USD from the U.S. Department of Health & Human Services.
A STTR Phase I contract was awarded to Simpore in July, 2017 for $225,000.0 USD from the U.S. Department of Health & Human Services.
A STTR Phase II contract was awarded to Simpore in April, 2017 for $750,000.0 USD from the National Science Foundation.
A STTR Phase I contract was awarded to Simpore in July, 2015 for $225,000.0 USD from the National Science Foundation.
A SBIR Phase I contract was awarded to Simpore for $155,819.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Simpore for $153,245.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Simpore for $184,665.0 USD from the U.S. Department of Health & Human Services.